AU2022234045B2 - Sn-38 derivative, nano-particles containing said derivative, medicine, and method for producing said nano-particles - Google Patents

Sn-38 derivative, nano-particles containing said derivative, medicine, and method for producing said nano-particles Download PDF

Info

Publication number
AU2022234045B2
AU2022234045B2 AU2022234045A AU2022234045A AU2022234045B2 AU 2022234045 B2 AU2022234045 B2 AU 2022234045B2 AU 2022234045 A AU2022234045 A AU 2022234045A AU 2022234045 A AU2022234045 A AU 2022234045A AU 2022234045 B2 AU2022234045 B2 AU 2022234045B2
Authority
AU
Australia
Prior art keywords
cancer
group
compound
salt
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2022234045A
Other languages
English (en)
Other versions
AU2022234045A1 (en
Inventor
Hitoshi Kasai
Yoshitaka Koseki
Keita TANITA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Original Assignee
Japan Science and Technology Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Agency filed Critical Japan Science and Technology Agency
Publication of AU2022234045A1 publication Critical patent/AU2022234045A1/en
Application granted granted Critical
Publication of AU2022234045B2 publication Critical patent/AU2022234045B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
AU2022234045A 2021-03-12 2022-01-14 Sn-38 derivative, nano-particles containing said derivative, medicine, and method for producing said nano-particles Active AU2022234045B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021040799 2021-03-12
JP2021-040799 2021-03-12
PCT/JP2022/001163 WO2022190626A1 (ja) 2021-03-12 2022-01-14 Ｓｎ－３８誘導体、当該誘導体を含むナノ粒子、医薬及び当該ナノ粒子の製造方法

Publications (2)

Publication Number Publication Date
AU2022234045A1 AU2022234045A1 (en) 2023-08-31
AU2022234045B2 true AU2022234045B2 (en) 2025-05-29

Family

ID=83226544

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022234045A Active AU2022234045B2 (en) 2021-03-12 2022-01-14 Sn-38 derivative, nano-particles containing said derivative, medicine, and method for producing said nano-particles

Country Status (6)

Country Link
US (1) US20240300979A1 (https=)
EP (1) EP4306527A4 (https=)
JP (1) JP7626491B2 (https=)
CN (1) CN117015545A (https=)
AU (1) AU2022234045B2 (https=)
WO (1) WO2022190626A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115844891B (zh) * 2022-11-04 2025-02-11 沈阳药科大学 二硫键桥连的sn38二聚体前药及其自组装纳米粒、制备方法与应用
AU2023390747A1 (en) 2022-12-09 2025-06-26 Japan Science And Technology Agency Compound, nanoparticles, medicine and method for producing nanoparticles

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011155501A1 (ja) * 2010-06-11 2011-12-15 独立行政法人科学技術振興機構 薬剤多量体微粒子及びその製造方法
CN107669626A (zh) * 2017-09-03 2018-02-09 河南师范大学 一种高载药量的还原敏感的药物传递系统的制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015012904A2 (en) 2012-12-13 2015-01-29 Immunomedics, Inc. Antibody-sn-38 immunoconjugates with a cl2a linker
AU2014293670B2 (en) 2013-07-23 2019-08-01 Immunomedics, Inc. Antibody-SN-38 immunoconjugates with a CL2A linker
TWI851577B (zh) 2018-06-07 2024-08-11 美商思進公司 喜樹鹼結合物
JP2021040799A (ja) 2019-09-09 2021-03-18 西川　基守 パチンコ遊技機

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011155501A1 (ja) * 2010-06-11 2011-12-15 独立行政法人科学技術振興機構 薬剤多量体微粒子及びその製造方法
CN107669626A (zh) * 2017-09-03 2018-02-09 河南师范大学 一种高载药量的还原敏感的药物传递系统的制备方法及其应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DONGXUAN HE et al., 'Self-assembling nanowires of an amphiphilic camptothecin prodrug derived from homologous derivative conjugation', CHEMICAL COMMUNICATIONS. 2016, vol. 52(98), pages 14145- 14148 *

Also Published As

Publication number Publication date
WO2022190626A1 (ja) 2022-09-15
EP4306527A4 (en) 2025-02-19
US20240300979A1 (en) 2024-09-12
JPWO2022190626A1 (https=) 2022-09-15
AU2022234045A1 (en) 2023-08-31
JP7626491B2 (ja) 2025-02-04
EP4306527A1 (en) 2024-01-17
CN117015545A (zh) 2023-11-07

Similar Documents

Publication Publication Date Title
RU2489423C2 (ru) Водорастворимые аналоги сс-1065 и их конъюгаты
TWI316942B (en) Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
US12152048B2 (en) Nitroxoline prodrug and use thereof
AU2022234045B2 (en) Sn-38 derivative, nano-particles containing said derivative, medicine, and method for producing said nano-particles
AU2008331516A1 (en) Biocompatible biodegradable fumagillin analog conjugates
US20140235568A1 (en) Gemcitabine amide derivative and preparation method and use thereof
US20220194942A1 (en) 3,6-METHANO-1H-PYRROLO[3,2-b]PYRIDINE AND 3,6-METHANO-1H-PYRROLO[3,2-c]PYRIDINE COMPOUNDS AND MEDICAMENTS USING SAME
US20170081286A1 (en) 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof
US20250026751A1 (en) Cocrystal
US20170057973A1 (en) Water-soluble taxane derivatives and uses thereof
CN114149395B (zh) 一种苯并环戊烯酮衍生物、其制备方法及医药用途
WO2005061492A1 (ja) 含窒素複素環化合物およびそれらを有効成分とする薬剤
EP4631949A1 (en) Compound, nanoparticles, medicine and method for producing nanoparticles
JP2021514353A (ja) ベンゾジアゼピン誘導体塩酸塩および結晶形、その製造方法および用途
EP4393906A1 (en) Solid form of indole compound, preparation method therefor and use thereof
WO2025162217A1 (zh) 一种含硫杂环衍生物及其在医药上的应用
WO2024229175A2 (en) Delivery of therapeutic alkaloid compounds
CA3013183C (en) Cocrystal
HK40069202A (en) Cocrystal
KR20110101488A (ko) 올란자핀 지나포에이트염 및 이의 용도
TW202130619A (zh) 硝羥喹啉前藥及其用途
JP2002201168A (ja) シクロヘキサン誘導体

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)